346 related articles for article (PubMed ID: 19733367)
1. Restorative approaches in Parkinson's Disease: which cell type wins the race?
Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
[TBL] [Abstract][Full Text] [Related]
2. Midbrain-derived neural stem cells: from basic science to therapeutic approaches.
Storch A; Sabolek M; Milosevic J; Schwarz SC; Schwarz J
Cell Tissue Res; 2004 Oct; 318(1):15-22. PubMed ID: 15503150
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cells and neurodegeneration.
Storch A; Schwarz J
Curr Opin Investig Drugs; 2002 May; 3(5):774-81. PubMed ID: 12090552
[TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
5. Stem cell therapy for Parkinson's disease.
Takahashi J
Expert Rev Neurother; 2007 Jun; 7(6):667-75. PubMed ID: 17563250
[TBL] [Abstract][Full Text] [Related]
6. Stem-cell-based strategies for the treatment of Parkinson's disease.
Parish CL; Arenas E
Neurodegener Dis; 2007; 4(4):339-47. PubMed ID: 17627139
[TBL] [Abstract][Full Text] [Related]
7. Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats.
Kallur T; Darsalia V; Lindvall O; Kokaia Z
J Neurosci Res; 2006 Dec; 84(8):1630-44. PubMed ID: 17044030
[TBL] [Abstract][Full Text] [Related]
8. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
[TBL] [Abstract][Full Text] [Related]
10. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
[TBL] [Abstract][Full Text] [Related]
11. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum.
Darsalia V; Kallur T; Kokaia Z
Eur J Neurosci; 2007 Aug; 26(3):605-14. PubMed ID: 17686040
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cells and Parkinson's disease.
Storch A; Schwarz J
J Neurol; 2002 Oct; 249 Suppl 3():III/30-2. PubMed ID: 12522569
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule.
Ourednik V; Ourednik J; Xu Y; Zhang Y; Lynch WP; Snyder EY; Schachner M
Stem Cells; 2009 Nov; 27(11):2846-56. PubMed ID: 19785036
[TBL] [Abstract][Full Text] [Related]
14. Pluripotent stem cells as new drugs? The example of Parkinson's disease.
Preynat-Seauve O; Burkhard PR; Villard J; Zingg W; Ginovart N; Feki A; Dubois-Dauphin M; Hurst SA; Mauron A; Jaconi M; Krause KH
Int J Pharm; 2009 Nov; 381(2):113-21. PubMed ID: 19782880
[TBL] [Abstract][Full Text] [Related]
15. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?
Arias-Carrión O; Yuan TF
Med Hypotheses; 2009 Nov; 73(5):757-9. PubMed ID: 19467573
[TBL] [Abstract][Full Text] [Related]
16. Stem cells may reshape the prospect of Parkinson's disease therapy.
Sonntag KC; Simantov R; Isacson O
Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
[TBL] [Abstract][Full Text] [Related]
17. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
Taylor H; Minger SL
Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
[TBL] [Abstract][Full Text] [Related]
18. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
19. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.
O'Keeffe FE; Scott SA; Tyers P; O'Keeffe GW; Dalley JW; Zufferey R; Caldwell MA
Brain; 2008 Mar; 131(Pt 3):630-41. PubMed ID: 18202103
[TBL] [Abstract][Full Text] [Related]
20. In vitro assays for neural stem cell differentiation: induction of dopaminergic phenotype.
Daadi MM
Methods Mol Biol; 2008; 438():205-12. PubMed ID: 18369760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
